Equities researchers at William Blair issued their FY2028 earnings estimates for Tempest Therapeutics in a research report ...

Research analysts at William Blair issued their Q1 2026 earnings estimates for shares of argenx in a research note issued on Monday, March 17th. William Blair analyst M. Minter forecasts that the ...

In a report released today, Ryan Daniels from William Blair reiterated a Buy rating on HealthStream (HSTM – Research Report). The company’s ...

Since the yoga-wear maker makes most of its products in countries targeted with outsize tariffs, William Blair says the ...

William Blair analyst Ryan Merkel maintained a Hold rating on MSC Industrial (MSM – Research Report) today. The company’s shares opened today ...

CBOE), following the company's latest earnings report. CBOE Holdings reported an adjusted EPS of $2.10, falling short of both William Blair's estimate of $2.12 and the consensus estimate of $2.13.

CentralReach has tapped investment bank William Blair to weigh a potential sale ... said CentralReach is doing about $75 million in earnings before deductions like taxes and interest.

The firm believes the company’s valuation remains attractive, with DocuSign trading at 16.9x the firm’s calendar 2026 free cash flow estimate. William Blair sees room for margin expansion in ...

On Friday, William Blair analysts remained bullish on AAON Inc (NASDAQ:AAON), maintaining their Outperform rating despite lowering their first-half 2025 earnings estimates. The revision reflects ...